PubMed

Carboplatin plus gemcitabine repeating doublet therapy in recurrent breast cancer.

Nagourney RA, Flam M, Link J, Hager S, Blitzer J, Lyons W, Sommers BL, Evans S.

Clin Breast Cancer. 2008 Oct;8(5):432-5.PMID: 18952557 [PubMed - indexed for MEDLINE]Related articles

Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group.

Brewer CA, Blessing JA, Nagourney RA, Morgan M, Hanjani P.

Gynecol Oncol. 2006 Nov;103(2):446-50. Epub 2006 Apr 27.PMID: 16643994 [PubMed - indexed for MEDLINE]Related articles

Ex vivo programmed cell death and the prediction of response to chemotherapy.

Nagourney RA.

Curr Treat Options Oncol. 2006 Mar;7(2):103-10. Review.PMID: 16455021 [PubMed - indexed for MEDLINE]Related articles

Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

Brewer CA, Blessing JA, Nagourney RA, McMeekin DS, Lele S, Zweizig SL.

Gynecol Oncol. 2006 Feb;100(2):385-8. Epub 2005 Nov 4.PMID: 16271750 [PubMed - indexed for MEDLINE]Related articles

Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics.

Nagourney RA, Sommers BL, Harper SM, Radecki S, Evans SS.

Br J Cancer. 2003 Nov 3;89(9):1789-95.PMID: 14583785 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.

Nagourney RA, Brewer CA, Radecki S, Kidder WA, Sommers BL, Evans SS, Minor DR, DiSaia PJ.

Gynecol Oncol. 2003 Jan;88(1):35-9.PMID: 12504624 [PubMed - indexed for MEDLINE]Related articles

PC-SPES.

Nagourney RA.

J Med Food. 2002 Fall;5(3):107-8. No abstract available. PMID: 12495582 [PubMed - indexed for MEDLINE]Related articles

TCL-1, MTCP-1 and TML-1 gene expression profile in non-leukemic clonal proliferations associated with ataxia-telangiectasia.

Chun HH, Castellví-Bel S, Wang Z, Nagourney RA, Plaeger S, Becker-Catania SG, Naeim F, Sparkes RS, Gatti RA.

Int J Cancer. 2002 Feb 20;97(6):726-31.PMID: 11857346 [PubMed - indexed for MEDLINE]Related articles

Gemcitabine plus cisplatin in breast cancer.

Nagourney RA.

Oncology (Williston Park). 2001 Feb;15(2 Suppl 3):28-33.PMID: 11252886 [PubMed - indexed for MEDLINE]Related articles

Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients.

Nagourney RA, Link JS, Blitzer JB, Forsthoff C, Evans SS.

J Clin Oncol. 2000 Jun;18(11):2245-9.PMID: 10829044 [PubMed - indexed for MEDLINE]Related articles

Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer.

Nagourney RA.

Gynecol Oncol. 2000 Jan;76(1):143. No abstract available. PMID: 10620464 [PubMed - indexed for MEDLINE]Related articles

2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.

Nagourney RA, Evans SS, Messenger JC, Su YZ, Weisenthal LM.

Br J Cancer. 1993 Jan;67(1):10-4.PMID: 8094002 [PubMed - indexed for MEDLINE]Related articlesFree article

Multidrug resistance in acute myeloid leukemia.

Nagourney RA.

J Natl Cancer Inst. 1991 Oct 2;83(19):1418-9. No abstract available. PMID: 1920485 [PubMed - indexed for MEDLINE]Related articles

Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues.

Nagourney RA, Messenger JC, Kern DH, Weisenthal LM.

Cancer Chemother Pharmacol. 1990;26(5):318-22.PMID: 1698567 [PubMed - indexed for MEDLINE]Related articles

Radiation response of cells from human tumor biopsies as assessed by a dye exclusion technique: a possible predictive assay.

Kurohara W, Colman M, Nagourney RA, Weisenthal LM, Swingle K, Redpath JL.

Int J Radiat Biol. 1989 Nov;56(5):767-70. No abstract available. PMID: 2479699 [PubMed - indexed for MEDLINE]Related articles

Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy.

Weisenthal LM, Su YZ, Duarte TE, Nagourney RA.

Prog Clin Biol Res. 1988;276:75-92. No abstract available. PMID: 3174684 [PubMed - indexed for MEDLINE]Related articles

Perturbation of in vitro drug resistance in human lymphatic neoplasms by combinations of putative inhibitors of protein kinase C.

Weisenthal LM, Su YZ, Duarte TE, Dill PL, Nagourney RA.

Cancer Treat Rep. 1987 Dec;71(12):1239-43.PMID: 3480042 [PubMed - indexed for MEDLINE]Related articles

Carcinoid carcinomatous meningitis.

Nagourney RA, Hedaya R, Linnoila M, Schein PS.

Ann Intern Med. 1985 Jun;102(6):779-82.PMID: 2581491 [PubMed - indexed for MEDLINE]Related articles

A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.

Nagourney RA, Fox P, Schein PS.

Cancer Res. 1978 Jan;38(1):65-8.PMID: 145314 [PubMed - indexed for MEDLINE]Related articlesFree article